COATS LONNEL
SEC CIK 1612528 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | CEO, Dir | 947.7K | $265.4K | — | 11 | 2022-02-28 | 2024-02-28 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
COATS LONNEL made no open-market trades at LXRX in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-29 | 2024-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | M - OptEx | — | +245.1K | 947.7K | +35% | — |
| D | 2024-02-29 | 2024-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | F - Tax | $2.62 | -61.4K | 1.10M | -5% | -$160.8K |
| 2023-11-17 | 2023-11-16 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | P - Purchase | $1.05 | +90.0K | 914.4K | +11% | +$94.5K | |
| 2023-11-13 | 2023-11-10 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | P - Purchase | $1.01 | +10.0K | 824.4K | +1% | +$10.1K | |
| 2023-06-29 | 2023-06-29 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | P - Purchase | $2.16 | +10.0K | 814.4K | +1% | +$21.6K | |
| M | 2023-06-26 | 2023-06-23+ | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | P - Purchase | $2.34 | +20.0K | 804.4K | +3% | +$46.8K |
| 2023-06-22 | 2023-06-22 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | P - Purchase | $2.31 | +40.0K | 784.4K | +5% | +$92.4K | |
| D | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | F - Tax | $2.17 | -51.0K | 744.4K | -6% | -$110.6K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | M - OptEx | — | +209.3K | 795.3K | +36% | — |
| DM | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | M - OptEx | — | +197.3K | 516.1K | +62% | — |
| D | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | CEO, Dir | F - Tax | $2.85 | -48.1K | 586.0K | -8% | -$137.0K |
Purchase Sale Sale after option exercise All abbreviations